"Keratin-18" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A type I keratin found associated with KERATIN-8 in simple, or predominately single layered, internal epithelia.
| Descriptor ID |
D053538
|
| MeSH Number(s) |
D05.750.078.593.450.300.800 D12.776.220.475.450.300.800 D12.776.860.607.300.800
|
| Concept/Terms |
Keratin-18- Keratin-18
- Keratin 18
- Endo-B Cytokeratin
- Cytokeratin, Endo-B
- Endo B Cytokeratin
- Cytokeratin-18
- Cytokeratin 18
- Cytokeratin D
|
Below are MeSH descriptors whose meaning is more general than "Keratin-18".
Below are MeSH descriptors whose meaning is more specific than "Keratin-18".
This graph shows the total number of publications written about "Keratin-18" by people in this website by year, and whether "Keratin-18" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2015 | 1 | 1 | 2 |
| 2016 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2025 | 0 | 1 | 1 |
| 2026 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Keratin-18" by people in Profiles.
-
Noninvasive Detection of Occult yet Significant Liver Pathology in Alanine Aminotransferase-Normal Chronic Hepatitis B: A Multicenter Study. J Infect Dis. 2026 Mar 17; 233(3):528-540.
-
Identification and validation of RIPK3 as a novel biomarker to predict outcomes in patients with acute decompensation of cirrhosis. J Hepatol. 2026 01; 84(1):99-112.
-
Emricasan Improves Liver Function in Patients With Cirrhosis and High Model for End-Stage Liver Disease Scores Compared With Placebo. Clin Gastroenterol Hepatol. 2019 03; 17(4):774-783.e4.
-
Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease. Liver Int. 2016 08; 36(8):1213-20.
-
Poor Inter-test Reliability Between CK18 Kits as a Biomarker of NASH. Dig Dis Sci. 2016 Mar; 61(3):905-12.
-
Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis. Toxicol Appl Pharmacol. 2015 Mar 15; 283(3):168-77.
-
Use of monitoring levels of soluble forms of cytokeratin 18 in the urine of patients with superficial bladder cancer following intravesical Ad-IFNa/Syn3 treatment in a phase l study. Cancer Gene Ther. 2014 Mar; 21(3):91-4.
-
Development and characterization of a surgical mouse model of reflux esophagitis and Barrett's esophagus. J Gastrointest Surg. 2014 Feb; 18(2):234-40; discussion 240-1.
-
Plasma biomarkers of lower gastrointestinal and liver acute GVHD. Blood. 2012 Mar 22; 119(12):2960-3.